Related Experiment Video
Updated: Sep 22, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Metformin-associated Lactic Acidosis with Hypoglycemia during the COVID-19 Pandemic
Kana Takayama1, Yoshinari Obata1, Yumiko Maruo1
1Department of Diabetes, Metabolism and Endocrinology, Osaka Police Hospital, Japan.
Abstract:
Metformin-associated lactic acidosis (MALA) is an extremely rare but life-threatening adverse effect of metformin treatment. The lifestyle changes associated with the coronavirus disease 2019 (COVID-19) pandemic may increase the potential risk of MALA development in patients with diabetes. We herein report a 64-year-old Japanese man taking a small dose of metformin who presented with MALA accompanied by hypoglycemia secondary to increased alcohol consumption triggered by lifestyle changes during the pandemic. Physicians should prescribe metformin judiciously to prevent MALA development and pay close attention to lifestyle changes in patients at risk for MALA during the COVID-19 pandemic.
Insights
Metformin-associated lactic acidosis (MALA) is a rare but severe risk of metformin. COVID-19 pandemic lifestyle changes, like increased alcohol intake, may heighten MALA risk in diabetic patients.
Area of Science:
- Endocrinology
- Pharmacology
- Critical Care Medicine
Background:
- Metformin is a widely prescribed oral hypoglycemic agent for type 2 diabetes.
- Metformin-associated lactic acidosis (MALA) is a rare but potentially fatal adverse drug reaction.
- The COVID-19 pandemic introduced lifestyle changes that could impact medication safety.
Observation:
- A 64-year-old Japanese male patient on a low-dose metformin regimen presented with MALA.
- The patient also experienced hypoglycemia concurrently with MALA.
- Increased alcohol consumption, linked to pandemic-related lifestyle shifts, was identified as a trigger.
Findings:
- This case highlights a rare instance of MALA and hypoglycemia in a patient on low-dose metformin.
- The patient's increased alcohol intake, a consequence of pandemic lifestyle changes, precipitated the adverse event.
- This suggests a potential interaction between metformin, alcohol, and pandemic-induced behavioral changes.
Implications:
- Physicians must exercise caution when prescribing metformin, especially in patients susceptible to lifestyle changes.
- Close monitoring of patients on metformin is crucial during periods of significant lifestyle alteration, such as pandemics.
- Awareness of potential triggers like increased alcohol consumption is vital for preventing MALA during the COVID-19 pandemic.
Related Concept Videos
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: Biguanides and Glitazones
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Glinides

